|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
Pacific Highway, Chatswood, NSW 2067, AU
|
|
Noxopharm (ASX:NOX) is an Australian-based clinical-stage drug development company with offices in Sydney and New York. Veyonda is the first pipeline drug candidate which is being trialed as a treatment for a broad range of solid tumor cancers and for septic shock. Later generation drug candidates for large markets of unmet medical need such as brain and pancreatic cancer are being developed in an active R&D program. The fully-owned subsidiary, Pharmorage Pty Ltd, was created in 2020 and has a focus on inflammation and autoimmune diseases.
Likes and shares are not endorsements
|
Noxopharm Limited Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
75%
|
The widely used Noxopharm Limited email format is {first}.{last} (e.g. [email protected]) with 75% adoption across the company.
To contact Noxopharm Limited customer service number call here +61 2 91442223. To contact Noxopharm Limited customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.